Introduction {#Sec1}
============

In 1861, Prosper Ménière described the classical triad of episodic vertigo, fluctuating sensorineural hearing loss, tinnitus and a feeling of aural pressure, and attributed this syndrome to an inner ear labyrinthine dysfunction (Baloh [@CR6]). Many theories have been proposed regarding the pathophysiology of Meniere's disease, including anatomic abnormalities affecting endolymph resorption, vascular abnormalities, post-viral autoimmune mechanisms, and factors relating to water homeostasis (Merchant et al. [@CR34]; Minor et al. [@CR37]; Paparella [@CR41]). The first post-mortem temporal bone studies in subjects with a history of Meniere's disease discovered a ballooning distension of the inner ear fluid-filled endolymphatic space (Hallpike and Cairns [@CR21]; Yamakawa [@CR61]). However, hydrops has been reported in asymptomatic subjects (Merchant et al. [@CR34]; Rauch et al. [@CR46]), indicating that endolymphatic hydrops is likely a necessary but not sufficient condition for the development of Meniere's disease. Because of the close association of endolymphatic hydrops with Meniere's disease, an alteration in the expression of water and ion channels has been proposed to disrupt inner ear fluid homeostasis in Meniere's disease (Andrews [@CR5]; Semaan et al. [@CR52]; Ishiyama et al. [@CR25]). Numerous ion channels and water transporters involved in inner ear fluid homeostasis and maintaining the endolymphatic potential needed for hearing and balance function have been identified in the mammalian audiovestibular periphery (Beitz et al. [@CR8]; Hibino and Kurachi [@CR22]; Lang et al. [@CR27]; Salt et al. [@CR50]).

Aquaporins (AQPs) play a fundamental role in mediating bidirectional water transport across membranes by lowering the energy used for water permeation (Magni et al. [@CR32]; Verkman and Mitra [@CR59]). Presently, 13 members of the AQP family (AQP0--AQP12) are known (Agre et al. [@CR1]). At least eight AQPs have been described in the inner ear (Beitz et al. [@CR7]; Huang et al. [@CR23]; Li and Verkman [@CR28]; Lopez et al. [@CR30]; Merves et al. [@CR35]; Mhatre et al. [@CR36]; Sawada et al. [@CR51]; Stankovic et al. [@CR53]; Takumi et al. [@CR56]). The immunolocalization of AQP1, 4, and 6 has recently been described in the human inner ear obtained from subjects with normal hearing and balance, and the localization demonstrates conservation across animal models (Lopez et al [@CR30]).

AQP1, an osmotic water channel in the kidney, brain, vascular system, and other tissues, has been hypothesized to function as a cGMP-gated cation channel (Boassa and Yool [@CR10]; Boassa et al. [@CR11]). The role of AQP1 that localizes to mesenchymal cells in the animal and human cochlea and vestibule has been proposed to be the transport of water molecules external to the endolymphatic compartment, regulating the osmotic environment adjacent to the scala media (Merves et al. [@CR35]; Stankovic et al. [@CR53]; Takumi et al. [@CR56]).

AQP4 is critical for the movement of water from the blood or cerebrospinal fluid into and out of the brain tissue and is localized in the endfeet membranes directly in contact with the basement membranes (Amiry-Moghaddam and Ottersen [@CR2]; Amiry-Moghaddam et al. [@CR4]). In the inner ear, AQP4 is restricted to epithelial cells in the organ of Corti and vestibular supporting cells and has been hypothesized to offset local increases in K^+^ ion concentration in supporting cells (Beitz et al. [@CR8]; Takumi et al [@CR56]; Lopez et al. [@CR30]). AQP4 probably plays a critical role in hearing, as the AQP4 knockout mouse models exhibit impaired auditory function, although the inner ear morphology is normal (Li and Verkman [@CR28]). AQP4 site-specific anchoring and localization is dependent upon α-syntrophin (Neely et al. [@CR39]), and defects in α-syntrophin are associated with AQP4 dysfunction (Amiry-Moghaddam et al. [@CR3], [@CR4]).

AQP6 co-localizes with H^+^ATPase in the acid-secreting intercalated cells in the renal collecting ducts, and its expression is regulated by acid-base conditions (Promeneur et al. [@CR44]; Yasui et al. [@CR62]); it may function as a nitrate channel (Ikeda et al. [@CR26]). Immunoreactivity for AQP6 has been localized to the sub-apical vestibular supporting cell cytoplasm in the human inner ear (Lopez et al. [@CR30]) and in the mice and rat (Perin et al. [@CR42]; Taguchi et al. [@CR55]). To our knowledge, an AQP6 knockout mouse is not available, and the role of AQP6 in the inner ear is unknown. In the inner ear, protons need to be actively secreted into the endolymph in the cochlea in order to maintain a pH of 7.4, because of the strongly positive potential of the endolymph (+80 mV); thus, AQP6 may be involved acid-base homeostasis, as there is a constant passive efflux of protons from the endolymph (Beitz et al. [@CR8]; Taguchi et al. [@CR55]).

In addition to AQPs, other pathways for water transport include that via co-transporters such as the Na^+^K^+^2Cl co-transporter (NKCC) (Zelenina et al. [@CR63]; Russell [@CR49]). In the cochlea, NKCC1 is located in marginal cells, in spiral ligament fibrocytes, and in the dark cells of the vestibule and Scarpa's ganglia (Delpire et al. [@CR17]). Of note, NKCC1 knockout mice are deaf and exhibit balance disorders; histopathology reveals a collapse of the endolymphatic space (Delpire et al. [@CR17]; Dixon et al. [@CR18]; Flagella et al. [@CR20]). Another ion channel, Na^+^K^+^ATPase, is the predominant factor for maintaining the osmotic gradient across the plasma membrane by providing the force for water transport across AQPs, and its localization in the inner ear has been documented (Zelenina et al. [@CR63]; Ross et al. [@CR47]; Pitovski and Kerr [@CR43]).

In the present study, we have investigated (1) the localization and mRNA expression of AQP1, 4, and 6 in the macula utriculi obtained from patients diagnosed with Meniere's disease, (2) the immunolocalization of proteins related to endolymphatic homeostasis, viz., Na^+^K^+^ATPase and NKCC1, and (3) the co-localization of α-syntrophin with AQP4. The findings are compared with those from the macula utriculi obtained from acoustic neuroma patients and with those from utricles obtained at autopsy from subjects with documented normal hearing and balance.

Materials and methods {#Sec2}
=====================

**Specimens** The Institutional Review Board (IRB) of UCLA approved this study. Appropriate informed consent was obtained from each patient before inclusion in the investigation. The temporal bones used in the present study are part of the Human Temporal Bone Consortium for Research Resource Enhancement funded by the National Institutes of Health (NIH), National Institute on Deafness and Other Communication Disorders (NIDCD).Utricular maculae were surgically obtained from patients who had with intractable Meniere's disease and who had elected to undergo transmastoid labyrinthectomy. All patients had recurrent vertigo spells, despite medical management, and had non-functional hearing in the operated ear. All patients met the 1995 AAO-HNS criteria for definite Meniere's disease (Committee on Hearing and Equilibrium [@CR13]). Utricular maculae obtained from patients with acoustic neuroma that required the translabyrinthine approach for resection were also used. Human temporal bone specimens were obtained post-mortem from six subjects with a history documenting a lack of auditory or vestibular symptoms (3 female and 3 male, age ranging from 83 to 97 years old, average age: 87). Post-mortem time ranged from 4 to 9 h, with an average of 6.8 h. The six patients with Meniere's disease (2 female and 4 male) had ages ranging from 66 to 84 years old (average age: 76). The six patients with acoustic neuroma (3 female and 3 male) were aged 41--73 years old (average age: 49).

**Tissue processing for immunohistochemistry** Immediately after removal at surgery (Meniere's disease and acoustic neuroma specimens) and microdissection (autopsy), the vestibular endorgans were immersed in 4% paraformaldehyde in sodium phosphate buffer (0.11 M, pH 7.4) and kept in this solution for 12--24 h. Thereafter, the fixative was removed, and the utricles were washed with phosphate-buffered saline solution (PBS; 0.1 M, pH 7.2).

**Cryoprotection and sectioning** Utricular endorgans from surgery or autopsy were immersed first in sucrose 30% (in PBS) for 3 days and then embedded in Tissue Tek (O.C.T. compound, Polysciences, Warrington, Pa., USA). Before sectioning, the utricles were placed on Teflon-embedding molds filled with Tissue Tek and properly oriented under the dissecting microscope to obtain longitudinal sections by using the nerve stump of the macula as reference. Cryostat serial sections (12 μm) were obtained by using a Microm-HM550 Cryostat. The sections were mounted on Superfrost Plus glass slides (Fisher Scientific, Pittsburgh, Pa., USA) and stored at −80°C until used.

**Immunofluorescence staining** Cryostat sections were rehydrated with PBS for 10 min and incubated at room temperature for 1 h with a blocking solution containing 1% bovine serum albumin fraction-V (Sigma, St. Louis, Mo., USA), 1% Triton X-100 (Sigma) in PBS. Next, the solution was removed, and the tissue sections were incubated with the primary polyclonal antibodies (raised in rabbit) against AQP1 and 6 (1:500 in PBS; from Alpha Diagnostic International \[ADI\], Tex., USA). Rabbit polyclonal antibodies against AQP4 (1:500 ADI, Tex. or 1:1000 from Santa Cruz, Calif., USA) were used. Tissue sections were incubated overnight at 4°C in a humid chamber. The secondary antibodies (against rabbit) labeled with Alexa 594 (1:1000 in PBS; Invitrogen, Carlsbad, Calif., USA) were applied and incubated for 1 h at room temperature in the dark. At the end of the incubation, sections were washed with PBS, and phalloidin Oregon green (1:50 in PBS; Invitrogen) was applied for 5 min. Tissue sections were washed again with PBS and covered with a water-soluble mounting media (Vectashield, Vector Labs, Burlingame, Calif., USA).Macula utriculi sections were immunoreacted with the following antibodies: mouse monoclonal antibodies against the α5 subunit of the Na^+^K^+^ATPase (1:500, Hybridoma Bank, University of Iowa, Iowa, USA), rabbit polyclonal affinity purified antibodies against NKCC1 (1:1000, ADI, Texas), α-syntrophin (1:1000, Abcam, Cambridge, Mass., USA), and myosin VIIa (1:500, Abcam). For co-localization, a mixture of polyclonal and monoclonal antibodies was applied: myosin VII with Na^+^K^+^ATPase or NKCC1 with Na^+^K^+^ATPase.

**Immunohistochemical controls** As positive controls, cryostat sections from human kidney (AQP4 and AQP6) and human red blood cells (AQP1), and human, rat, and mouse inner ear were incubated with AQP antibodies. Kidney and inner ear tissue and sections from rats were processed in an identical fashion as human utricular sections with regard to fixation time, embedding, sectioning, and immunostaining. Normal human kidney frozen sections were acquired from the Bio-chain Institute (Hayward, Calif., USA). These sections were fixed with 2% paraformaldehyde for 5 min prior to immunofluorescence staining.As negative controls, utricular macula cryostat sections obtained from surgery or autopsy were immunohistochemically stained without the primary antibody or with antibodies that had been pre-absorbed with the corresponding blocking peptide used to generate the antibody. Antibody absorption was made by incubating the primary antibody with the blocking peptide (at 1 μg/1 μg). The mixture was then placed at 37°C for 1 h, after which immunohistochemical staining was performed as described above. In both cases, only a faint background in human utricular sections was observed. The cross-reactivities of the AQP antibodies have been previously described in detail (Lopez et al. [@CR30]).

**Image acquisition** Immunostained tissue sections were viewed and imaged with an Olympus BX51 fluorescent microscope (Olympus America, N.Y., USA) equipped with an Olympus DP70 digital camera. To provide unbiased comparisons of the immunoreactive signal between each specimen, all images were captured by using strictly the same camera settings. Images were acquired by means of MicroSuite Five software (Olympus America). All images were prepared with the Adobe Photoshop software program run on a Dell Precision 380 computer. This program was used to optimize brightness and contrast. The image content was neither enhanced nor changed. To analyze for an effect of optimization of the photomicrograph image, quantitative analysis was conducted before and after optimization. Differences in measurements were not significantly different before and after optimization (*P*=0.646). No further modifications to the image were made for the quantitative analysis.

**Quantification of immunostained areas** For quantitative immunocytochemistry, macula utriculi cryosections obtained from Meniere's disease, acoustic neuroma, or normative post-mortem patients were simultaneously immunoreacted with the same batch of antibodies and buffers, and the antigen-antibody reaction was stopped at the same time. To minimize bias in the analysis, the observer was "blinded" to the identity of the tissue samples to be analyzed. A second person not blinded to the sample identity, coded each sample. To determine the possible presence of regional variations in the immunostaining pattern, cryostat serial cross sections were made of the whole utricle. One section (separated every 200 μm) was immunostained for a specific marker and used for image observation and analysis. Observations from the periphery, intermediate, and central portions of the epithelia were made at low magnification (×100 and ×200). Image acquisition and analyses were made on micrographs acquired at ×400. The immunostained area for each AQP, Na^+^K^+^ATPase, NKCC1, and syntrophin was measured in these three different regions of the sensory epithelia.The area immunostained in utricular macula sections was quantified by using the computer image analysis software *ImageJ* (available free over the Internet: <http://rsb.info.nih.gov/ij/index.html>) with the protocol described by Rangan and Tesch ([@CR45]). The digital image (captured as described above) was opened by using *ImageJ* program and converted to grayscale (*Image/Type/8-bit*). The threshold for staining detection was set by selecting (*Image/Adjust/Threshold*), and the threshold level was adjusted. The image was then converted to binary (black and white). The immunostained area of interest was defined by using the polygon tool. To determine the area stained within the region of interest, *Analyze/Analyze Particles* was selected on the tool bar, the "Masks" tool was selected from the menu, and a summary of results appeared showing the total area that was immunostained within the region of interest.

**Statistical analysis** For each specimen, mean values of the immunostained area were averaged and subjected to one-way repeated measures analysis of variance. Six utricles per type of specimen were used for quantification (total: 18). Comparisons were made between the three types of specimen: Meniere's disease vs. acoustic neuroma, Meniere's disease vs. normative post-mortem, and acoustic neuroma vs. normative post-mortem. Values were considered statistically significant at *P*≤0.05. Results were expressed as the percentage from the "control" utricles obtained for autopsy. The Sigma Stat 3.1 software program (Sigma Stat, Ashburn, Va., USA) was used for statistical analysis.

**Considerations on the use of vestibular endorgans obtained from autopsy and surgery for quantitative immunohistochemistry** Autolytic artifact secondary to fixation delay is unavoidable in human material. This effect is especially critical for examination by cytochemical techniques. To minimize post-mortem artifacts, we used temporal bones harvested between 3 and 9 h post-mortem. We selected specimens with a minimum degree of swollen calyces and autolysis (Ishiyama et al. [@CR24]; Lopez et al. [@CR30]). The quality of the microdissected endorgan tissue sections was further confirmed by staining with hematoxylin and eosin. In general, shorter post-mortem times were associated with better signal and a lower background. No effect of increasing age was seen with respect to the quality of immunoreactivity. The time of harvesting and fixation time for surgical specimens, i.e., Meniere's disease and acoustic neuroma, were better controlled. In the surgical cases, upon surgical extraction, tissue was immediately transported to the laboratory, and specimens were post-fixed for 24 h. In the case of post-mortem specimens, we found it much more difficult to control post-mortem time. By selecting specimens with a minimum degree of swollen calyces, we minimized post-mortem changes.

Real-time reverse transcription with polymerase chain reaction {#Sec3}
--------------------------------------------------------------

**Specimens** Surgically acquired utricular maculae from patients with Meniere's disease (2 male and 1 female, aged 63, 68, and 86 years) or acoustic neuroma (1 male and 2 female, aged 34, 44, and 57 years) were received in RNAlater (Ambion, Texas, USA) and taken immediately to the laboratory. Samples were placed overnight in the refrigerator at 4°C. The following day, the vials containing the specimens were placed at −80°C until the mRNA was extracted.

**Nucleotide sequence primer design** AQP primers were designed and validated by using mRNA from normal human kidney (Ambion); for AQP1: forward GTAGCCCTTGGACACCTC; reverse AGCCAAAGGACCGAGCAG (accession number NM198098.1); for AQP4: forward GGAGCAGGAATCCTCTATC; reverse AGACCATGACCAGCGGTA (accession number NM001650.4); for AQP6: forward CATTGGGAAGTTCACAGTCCA; reverse CGAAGTTGTAGATCAGTGAGGC (accession number NM001652.3); for the housekeeping gene D-glyceraldehyde-3-phosphate dehydrogenase (GADPH): forward ACAACTTTGGTATCGTGGAA; reverse (accession number NM002046.3). Each mRNA sequence was aligned with its corresponding genomic sequence by using the BLAST application (NCBI) to determine exon-intron boundaries. Every effort was made to identify a prime pair that spanned an intron. This step minimized the chance of amplifying a product from genomic DNA contamination of the RNA sample. Each primer was compared with the entire non-redundant GenBank nucleotide database by using the BLAST application (NCBI) to ensure that it recognized only the gene of interest. All primers were synthesized by Invitrogen.

**RNA extraction and reverse transcription** Total RNA was extracted from each utricle by using TRIzol Reagent (Invitrogene) as described by Lopez et al. ([@CR31]).For reverse transcription (RT) of total RNA, the following solutions were added to approximately 3 μg RNA: 10 μl Mixmaster-buffered mRNA (final concentration of 1×), 2 mM Oligo dT, 1 ml StrataScript, and nuclease-free H~2~O to give a total volume of 20 ml per tube. We also prepared one "no-template control" tube contained H~2~O in place of RNA for each sample. Samples were incubated in the thermocycler and exposed to the following conditions: 25°C for 5 min, 42°C for 40 min, and 95°C for 5 min. The samples were stored at −20°C until use.

**Real-time polymerase chain reaction** Amplification was performed with the single-color real-time polymerase chain reaction (PCR) system in a Stratagene Mx3000P. PCR tubes were prepared with 25 μl real-time PCR consisting of 50 ng cDNA, 12.5 μl 2× SYBR green PCR master mix (Superarray), 150 nM primer mix, and nuclease-free H~2~O to a total volume of 25 ml per tube. Thermal cycling conditions comprised an initial denaturation step at 95°C for 10 min, 40 cycles at 95°C for 10 s, 60°C for 20 s, and 72°C for 30 sc, followed by melting curves to display product dissociation characteristics. Each cDNA sample was evaluated for target genes of interest and a housekeeping gene. In addition, a no-template control sample was included for each primer set to verify that no reagents were contaminated with DNA, or that the primers did not produce signal by dimer formation. Primer sets were validated to ensure amplification of a single product with appropriate efficiency. Samples were run in duplicate, and the amplified products were analyzed by 4% agarose gel electrophoresis.

**Data analysis** The threshold cycle (C~t~) for each reaction (which is directly related to the amount of starting template in the reaction) was calculated within the exponential phase of the PCR by using Stratagene software MxPro V3. A correction was performed with a passive reference dye (Rox), which was present in the PCR master mix. Reactions with a Ct value 36 or with evidence of non-specificity (e.g., low melting temperatures or multiple peaks in melting point analysis) were excluded from the analysis. To correct for differences in both RNA quality and quantity between samples, data were normalized by using the housekeeping gene GADPH. The difference in C~t~ values (DC~t~) was then calculated for each gene by taking triplicate C~t~ values from three reactions and subtracting the mean C~t~ of the triplicates for the control gene (GADPH) for each cDNA sample at the same concentration. An additional difference in DC~t~ value (DDC~t~) was calculated for each gene by taking the triplicate DC~t~ values for each gene in Meniere's specimens and subtracting the mean DC~t~ value of the triplicates for acoustic neuroma specimens. The relative expression level was calculated by using the 2^−DDCt^ method (Livak and Schmittgen [@CR29]). Because of the small number of Meniere's and acoustic neuroma specimens, only qualitative comparisons were made of the individual mRNA expression levels for each AQP.

Results {#Sec4}
=======

**Immunohistochemical controls** AQP1 immunoreactivity in the human proximal tubules of the kidney and in human red blood cells is shown in Fig. [1](#Fig1){ref-type="fig"}a, a'. The AQP1 immunostaining pattern is similar to that in previously published reports (Huang et al. [@CR23]; Merves et al. [@CR35]; Stankovic et al. [@CR53]; Miyabe et al. [@CR38]). Figure [1](#Fig1){ref-type="fig"}b demonstrates AQP4 immunoreactivity in a cross section of the rat organ of Corti; the inner sulcus and outer sulcus cells are AQP4-immunoreactive. The AQP4 immunoreactivity in the rat collecting duct of the kidney presented in Fig. [1](#Fig1){ref-type="fig"}b' is also similar to that in previously published reports (Huang et al. [@CR23]; Li and Verkman [@CR28]; Mhatre et al. [@CR36]; Miyabe et al. [@CR38]), as is the AQP6 immunoreactivity in the intercalated cells of the collecting duct of the rat kidney (Fig. [1](#Fig1){ref-type="fig"}c; Ohshiro et al. [@CR40]). When the antibody against AQP4 is absorbed with the peptide used to generate the antibody, no signal is observed in the human macula utriculi (Fig. [1](#Fig1){ref-type="fig"}d; negative control). Na^+^K^+^ATPase immunoreactivity in the rat stria vascularis and spiral ligament (Fig. [1](#Fig1){ref-type="fig"}e) resembles that in previous studies (Ross et al. [@CR47]; Pitovski and Kerr [@CR43]), as does the NKCC1 immunostaining in the rat stria vascularis, spiral ligament, and spiral limbus (Fig. [1](#Fig1){ref-type="fig"}f; Delpire et al. [@CR17]; Flagella et al. [@CR20]; Crouch et al. [@CR16]). Figure [1](#Fig1){ref-type="fig"}g shows α-syntrophin in blood vessels of the mouse cerebellum, as has been previously reported (Amiry-Moghaddam et al. [@CR3]; Neely et al. [@CR39]). Fig. 1Immunohistochemical controls. **a** AQP1 immunoreactivity (*red*) in the human kidney. **a'** AQP1 immunoreactivity (*red*) in human red blood cells. AQP1 localizes on the membrane (*arrowheads*). **b** AQP4 immunoreactivity (*red*) in a cross section of the rat organ of Corti. Inner sulcus and outer sulcus cells are AQP4-immunoreactive (*arrowheads*). Phalloidin Oregon green staining was used to identify actin in the apical portion of supporting cells (*green*). **b'** AQP4 immunoreactivity in the rat kidney (*amber*) counterstained with hematoxylin (*blue* nuclei). **c** AQP6 immunoreactivity in the rat kidney (*amber*, *arrows*) counterstained with hematoxylin (*purple* nuclei). **d** Cross section of a human macula utriculi from an autopsy; AQP1 was absorbed with the corresponding peptide. No specific immunoreaction was detected. **e** Na^+^K^+^ATPase (*red*) in the rat stria vascularis (*SV*) and spiral ligament (*sl*). **f** NKCC1 in the rat SV, sl, and spiral limbus (*right*; *dark amber*). **g** α-Syntrophin in blood vessels of the mice cerebellum (*green*). *Bars* 50 µm (**a**, **b**, **e**, **f**), 10 µm (**a'**), 120 µm (**b'**), 40 µm (**c**), 45 µm (**d**), 25 µm (**g**)

AQP1 immunolocalization {#Sec5}
-----------------------

AQP1 immunofluorescence in sections of the utricular maculae from Meniere's disease patients (Fig. [2](#Fig2){ref-type="fig"}a) was similar to that of acoustic neuroma (Fig. [2](#Fig2){ref-type="fig"}a') and normal post-mortem subjects (Fig. [2](#Fig2){ref-type="fig"}a''). No changes were noted in the regional distribution of AQP1 within the epithelium in the utricular maculae from Meniere's patients. Immunoreactivity was seen within fibrocytes in the stroma underneath the sensory epithelia and within the trabecular perilymphatic tissue (Fig. [2](#Fig2){ref-type="fig"}a, a', a''). Quantitative immunofluorescence measurements for AQP1 showed no statistically significant differences between AQP1 immunoreactivity measurements from specimens from subjects with Meniere's disease compared with those from acoustic neuroma or autopsy subjects (Fig. [2](#Fig2){ref-type="fig"}a'''). Fig. 2AQP 1 (*aqp1*), AQP4 (*aqp4*), and AQP6 (*aqp6*) immunoreactivity in the utricular macula of Meniere's, acoustic, and autopsy patients. AQP1 immunoreactivity (*red*) in Meniere's disease (**a**), acoustic neuroma (**a'**), and autopsy specimens (**a''**) is localized to the fibrocytes beneath the overlying sensory epithelium (*se*, *arrow*) and to the fibrocytes in the underlying stroma (*st*, *double arrows*) in the utricular maculae (*lu* luminal region). AQP1 immunoreactivity was not present in the sensory epithelium itself. A quantitative comparison of AQP1 immunoreactivity between the three types of specimens (**a'''**) showed no statistically significant differences. AQP4 immunoreactivity (*red*) in Meniere's disease (**b**), acoustic neuroma (**b'**), and autopsy specimens (**b''**) was localized to the basal pole of supporting cells. The AQP4 immunoreactivity in the utricular macula from subjects with Meniere's disease (**b**) was significantly diminished in the sensory epithelium (*arrows*) when compared with that in acoustic neuroma (**b'**, *arrows*) and in autopsy material (**b''**, *arrows*). Quantitative immunoreactivity analysis (**b'''**) shows a statistically significant decrease in AQP4 immunoreactivity in Meniere's specimens when compared with acoustic neuroma and autopsy specimens. AQP6 immunoreactivity in Meniere's disease (**c**), acoustic neuroma (**c'**), and autopsy specimens (**c''**). In the utricular macula from subjects with Meniere's disease (**c**), AQP6 immunoreactivity (*red*) was diffusely distributed throughout the supporting cell in the sensory epithelium (*arrows*). In utricular maculae from patients with acoustic neuroma (**c'**) and normative subjects (**c''**), AQP6 immunoreactivity was polarized to the sub-apical portion of the supporting cells. An increased intensity and more diffuse expression of AQP6 (*red*) was noted in Meniere's disease (**c**) compared with acoustic neuroma (**c'**) and normative (**c''**) material. Quantitative immunoreactivity analysis (**c'''**) shows a statistically significant increase in AQP6 immunoreactivity in Meniere's specimens when compared with acoustic neuroma and autopsy specimens. Phalloidin Oregon green staining (*green*) was used to identify actin at the apical portion of the sensory epithelium. No co-localization was observed between AQP6 (*red*) and phalloidin (*green*) corroborating a sub-apical distribution in the supporting cell of utricular maculae derived from acoustic neuroma (**b**) and normative (**c**) samples. *Bars* 50 µm (**a--a''**, **b--b''**, **c--c''**)

AQP4 immunolocalization {#Sec6}
-----------------------

In specimens from Meniere's subjects, acoustic neuroma, and autopsy (Fig. [2](#Fig2){ref-type="fig"}b, b', b'' respectively), AQP4 expression was localized to the basal portion of supporting cells in the utricular sensory epithelium. No changes were noted in the regional distribution of AQP4 within the epithelium in the utricular maculae from Meniere's patients, whereas a significant decrease of AQP4 immunoreactivity was seen in the utricular maculae from patients with Meniere's disease (Fig. [2](#Fig2){ref-type="fig"}b) when compared with those from patients with acoustic neuroma (Fig. [2](#Fig2){ref-type="fig"}b') and with autopsy specimens (Fig. [2](#Fig2){ref-type="fig"}b''). Quantitative immunofluorescence measurements confirmed a decrease (statistically significant) of AQP4 immunoreactivity in specimens from Meniere's subjects compared with acoustic neuroma and autopsy specimens (Fig. [2](#Fig2){ref-type="fig"}b'''). Acoustic neuroma specimens showed no statistically significant alteration of AQP4 expression when compared with autopsy specimens.

AQP6 immunolocalization {#Sec7}
-----------------------

AQP6 immunoreactivity was distributed throughout the cytoplasm of vestibular supporting cells, from basal to apical regions, in Meniere's specimens (Fig. [2](#Fig2){ref-type="fig"}c). In contrast, AQP6 immunoreactivity was polarized to the sub-apical vestibular supporting cell in acoustic neuroma specimens (Fig. [2](#Fig2){ref-type="fig"}c') and in autopsy specimens (Fig. [2](#Fig2){ref-type="fig"}c''). In all cases, vestibular hair cells, nerve fibers, stromal cells, and blood vessels were non-immunoreactive. AQP6 did not co-localize with phalloidin staining, corroborating the sub-apical intracellular localization of AQP6. Quantitative immunofluorescence measurements showed a significant increase of AQP6 immunoreactivity in utricular macula from patients with Meniere's disease when compared with those from acoustic neuroma patients and autopsy specimens (Fig. [2](#Fig2){ref-type="fig"}c'''). Acoustic neuroma specimens showed no statistically significant alteration of AQP6 expression when compared with autopsy specimens.

Immunolocalization of proteins related to ion homeostasis in the macula utriculi of Meniere's patients {#Sec8}
------------------------------------------------------------------------------------------------------

NKCC1 immunoreactivity localized to the nerve fibers and calyces within the sensory epithelium of the macula utriculi in Meniere's specimens (Fig. [3](#Fig3){ref-type="fig"}a). Na^+^K^+^ATPase immunoreactivity showed a similar pattern of expression. Myosin VII immunoreactivity (Fig. [3](#Fig3){ref-type="fig"}b) was used to identify vestibular hair cells; nerve fibers terminals and calyces that surrounded the hair cells were immunoreactive for Na^+^K^+^ATPase. α-Syntrophin immunoreactivity was found in hair cell cytoplasm, in the basal region of supporting cells, and in stromal cells in specimens from Meniere's specimens (Fig. [3](#Fig3){ref-type="fig"}c). Similar immunoreactive patterns for Na^+^K^+^ATPase, NKCC1, and α-syntrophin were observed in autopsy specimens (not shown). Meniere's specimens showed no statistically significant alteration of Na^+^K^+^ATPase, NKCC1, or α-syntrophin immunoreactivity when compared with autopsy specimens (Fig. [3](#Fig3){ref-type="fig"}d). Utricular sections from acoustic neuroma were not stained with these antibodies, the sensory epithelium being devoid of nerve calyces. Fig. 3Immunohistochemical localization of protein related to ion homeostasis in Meniere's disease patients. **a** Immunoreactivity for Na^+^K^+^ATPase (*green*) and NKCC1 (*red*) is similarly located (*double arrows*; *lu* lumen, *st* stroma, *se* sensory epithelium). **b** Na^+^K^+^ATPase in nerve fibers terminals and calyces (*arrows*). Co-localization with myosin VIIa (*red*) helps to visualize the cytoplasm of vestibular hair cells (*hc*). **c** α-Syntrophin shows a ubiquitous distribution in the sensory epithelium. Hair cell (*hc*) cytoplasm (*arrows*) and the basal portion of supporting cells (*sc*, *double arrowheads*) are syntrophin immunoreactive. **d** Quantitative comparison of Na^+^K^+^ATPase, NKCC1, and syntrophin immunoreactivity between autopsy and Meniere's specimens reveals no statistically significant changes. *Bars* 26 µm (**a**, **b**), 28 µm (**c**)

Quantification and identification and of AQPs isoforms by real-time RT-PCR {#Sec9}
--------------------------------------------------------------------------

Isolated mRNA was subjected to real-time RT-PCR to detect the mRNA of AQP1, 4, and 6. A comparison of AQP1, 4, and 6 mRNA expression levels between Meniere's and acoustic neuroma specimens showed no differences (Fig. [4](#Fig4){ref-type="fig"}a). Electrophoresis examination of AQP mRNA amplification revealed that PCR yielded only one band for each AQP at the expected size (Fig. [4](#Fig4){ref-type="fig"}b). Fig. 4Quantification by real-time reverse transcription with the polymerase chain reaction (PCR) of AQP mRNAs extracted from Meniere's and acoustic neuroma utricles. **a** Individual mRNA expression in utricles from subjects with Meniere's disease (*md*) and acoustic neuroma (*an*) patients. **b** Electrophoresis of real-time PCR products of AQP1 (*1*), AQP4 (*4*), and AQP6 (*6*) amplified from Meniere's utricle. Molecular size markers (*m*) are indicated (ladder amplicon sizes of 100 bp, 50 bp, and 25 bp)
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**AQP1 immunolocalization and mRNA expression in Meniere's disease** AQP1 and AQP4 immunolocalization in the human inner ear is highly conserved across species (Lopez et al. [@CR30]; Beitz et al. [@CR7], [@CR8]; Li and Verkman [@CR28]; Merves et al. [@CR35]; Mhatre et al. [@CR36]; Stankovic et al. [@CR53]; Takumi et al. [@CR56]) indicative of their having an important role in the inner ear. In the present study, AQP1 immunolocalization in the utricular maculae acquired from patients with Meniere's disease is similar to that in acoustic neuroma and autopsy specimens; AQP1 is localized within the fibrocytes in the underlying stromal tissue and blood vessels. In a recent study, an alteration in AQP1 expression appears to mediate the response to corticosteroids in cerebral edema (Tran et al. [@CR57]), and intratympanic dexamethasone has been shown to be effective in the treatment of Meniere's disease (Boleas-Aguirre et al. [@CR12]). mRNA expression for AQP1 isoforms has also been detected by RT-PCR, with no differences being found between the AQP1 mRNA expression in specimens from Meniere's subjects compared with those from acoustic neuroma. This lack of differences in the levels of mRNA expression between specimens from patients with Meniere's disease vs. acoustic neuroma must be interpreted with caution, given the small sample of patients analyzed. Additionally, acoustic neuroma vestibular endorgans are pathological specimens and thus are not true "normative" specimens.

**AQP4 immunolocalization and mRNA expression in Meniere's disease** AQP4 expression was significantly diminished in vestibular endorgans from patients with Meniere's disease when compared with specimens from subjects with acoustic neuroma (surgical) and autopsy samples. In the normal human vestibular neuroepithelium, AQP4 has been localized to the basal pole of supporting cells (Lopez et al. [@CR30]), and vestibular supporting cells have been hypothesized to play an important role in ionic and water homeostasis, similar to astroglial cells in the brain (Takumi et al. [@CR56]). The decrease in AQP4 immunoreactivity in Meniere's specimens suggests a primary or secondary effect on water transport in Meniere's disease. A recent study on a mouse model for age-related hearing loss has demonstrated decreased AQP4 expression in the cochlea with increasing age (Christensen et al. [@CR15]). The AQP4 knockout mouse (-/-) exhibits significant hearing loss but no visible morphological damage or endolymphatic hydrops (Li and Verkman [@CR28]; Mhatre et al. [@CR36]). Moreover, in the human vestibular epithelium, the immunolocalization of AQP4 is intimately intertwined with the expression of the basement membrane protein, α-dystroglycan, in normal post-mortem macula utricle, saccule, and cristae (Ishiyama et al. [@CR24]). This interaction between the basement membrane protein, α-dystroglycan, and AQP4, might be affected by the thickening of the basement membrane observed in vestibular endorgans from patients with intractable Meniere's disease, a finding highly correlated with vestibular neuroepithelial degeneration (McCall et al. [@CR33]). Vacuolization of the supporting cell cytoplasm in the macula utriculi and crista obtained at surgery from Meniere's disease patients has also been noted. We have also detected mRNA for AQP4 isoforms by RT-PCR; however, no differences have been seen between the AQP4 mRNA expression in specimens from Meniere's subjects compared with those from acoustic neuroma. Again, this absence of differences must be interpreted with caution, given the small sample analyzed, and acoustic neuroma vestibular endorgans are pathological specimens and should not be considered as true "normative" specimens.

**AQP6 immunolocalization and mRNA expression in Meniere's disease** In specimens from patients with Meniere's disease, AQP6 expression was distributed throughout the supporting cell cytoplasm and demonstrated a significantly increased expression when compared with specimens from subjects with acoustic neuroma (surgical) and autopsy specimens. AQP6 expression was polarized to the sub-apical region of the supporting cells of the normative post-mortem subjects in the present study and in a previous study (Lopez et al. [@CR30]) and in vestibular endorgans acquired from patients with acoustic neuroma. In a study of AQP6 protein and mRNA expression in the rat inner ear and endolymphatic sac, AQP6 was localized to the membrane of intracellular vesicles (Taguchi et al. [@CR55]). Light- and electron-microscopic examination of vestibular endorgans acquired from patients with intractable Meniere's disease demonstrated an abundance of vesicles in the vestibular supporting cells (McCall et al. [@CR33]); this might have been related to the alterations in AQP4 and AQP6 expression in the supporting cells. The increased expression of AQP6 may reflect an altered acid-base balance in the inner ear of Meniere's disease. Studies have demonstrated that AQP6 is markedly upregulated in rats made chronically alkalotic with bicarbonate, indicating acid-base modulation (Promeneur et al. [@CR44]). Alternatively, AQP6 may act as a nitrate channel. Nitrate is an endogenous oxide of nitrogen produced by nitric-oxide synthase in response to various stimuli and is toxic in vivo (Vatassery et al. [@CR58]); recent studies have demonstrated the possible involvement of nitric oxide in response to oxidative stress in the inner ear (Ruan [@CR48]). The same caveat as that for AQP1 and AQP4 is also applicable here with respect to the lack of differences in the levels of AQP6 mRNA expression between specimens from patients with Meniere's disease vs. acoustic neuroma, given the small sample analyzed, and again, acoustic neuroma vestibular endorgans are pathological specimens and thus are not a true "normative" specimens.

**Proteins involved in water, ion transport, and endolymph production** We have localized NKCC1 immunoreactivity to the afferent calyceal nerve terminals of the sensory epithelia of utricular maculae. The NKCC1 co-transporter localizes to the basolateral membrane of dark cells and fibrocytes underlying the sensory epithelium and vestibular ganglia neurons similar to that in mice and gerbil (Delpire et al. [@CR17]; Crouch et al. [@CR16]). Because of the localization of NKCC1 in cellular components known for their production of endolymph, and because of the knowledge that knockout mice exhibit a collapse of the endolymphatic space (Delpire et al. [@CR17]; Dixon et al. [@CR18]; Flagella et al. [@CR20]), we had hypothesized that NKCC1 expression might be altered in Meniere's disease. However, in contrast to AQP4 and AQP6, no alteration has been seen in the distribution or intensity of the NKCC1 co-transporter expression in utricular maculae from patients with Meniere's disease compared with autopsy specimens.Na^+^K^+^ATPase is expressed in nerve calyces that surround type I hair cells and in the basolateral membrane of transitional cells and dark cells with a similar expression between specimens from Meniere's patients and autopsy. We have detected mRNA transcripts for Na^+^K^+^ATPase in surgically acquired utricles from patients with Meniere's disease and acoustic neuroma; the diminished expression of Na^+^K^+^ATPase mRNA in acoustic neuroma is likely to be secondary to the loss of calyceal endings (Beltran-Parrazal et al. [@CR9]). In the present study, we have also demonstrated syntrophin immunolocalization ubiquitously in the sensory epithelium and the underlying stroma with no apparent alteration in expression in utricular maculae acquired from Meniere's patients compared with those from autopsy specimens. Syntrophin co-localizes with AQP4 in both utricular maculae from post-mortem normative individuals and in Meniere's disease, and no immunohistochemical evidence has been obtained for an alteration in syntrophin to account for the diminished expression of AQP4 in the vestibular endorgans acquired from patients with Meniere's disease.The role of AQP6 in the inner ear is unknown. However, in the renal system, AQP6 co-localizes with H^+^-ATPase in intracellular vesicles of acid-secreting alpha-intercalated cells (Yasui et al. [@CR62]). Vacuolar H^+^-ATPase expression is dependent on regulation by the forkhead transcription factor Foxi1 in the kidney and the inner ear (Vidarsson et al. [@CR60]). Under normal conditions, both proteins are localized in the sub-apical portion of epithelial cells; therefore, AQP6 in the vestibular supporting cells probably co-localizes with H^+^-ATPase, which is expressed in cochlear supporting cells and the vestibular neuroepithelium (Stankovic et al. [@CR54]). Thus, the altered expression of AQP4 and AQP6 may reflect or induce a disturbance in fluid and ion homeostasis in Meniere's disease.An association of the inner ear aquaporins probably occurs with ephrins (Eph) and their receptors. The EphB2 receptor tyrosine kinase, a receptor that belongs to a group of molecules that control contact-mediated axon repulsion, may regulate ionic homeostasis and endolymph fluid production through macromolecular association with membrane channels that transport chloride, bicarbonate, and water (Cowan et al. [@CR14]; Dravis et al. [@CR19]). Ephrin-B2 is expressed in the vestibular supporting cells, and the knockout mouse exhibits abnormal K^+^ concentrations in the endolymph and diminished endolymph production (Dravis et al. [@CR19]). EphB2 and AQP1 form a stable macromolecular complex through their ability to bind to an adaptor protein. Mice lacking EphB2 exhibit vestibular dysfunction (Cowan et al. [@CR14]). AQP1 is present in blood vessels within the stromal tissue of the utricle and crista, and AQP4 and AQP6 are present in vestibular supporting cells, probably co-localizing with ephrin-B2.

**Meniere's disease and aquaporins** Detailed histopathological studies of vestibular endorgans from patients with Meniere's disease have demonstrated significant thickening of the basement membrane underlying the vestibular neuroepithelium (McCall et al. [@CR33]). The abnormally thickened basement membrane is probably dysfunctional, a significant factor given that the inner ear basement membrane plays an important role in ionic and water homeostasis. Attacks of vertigo and tinnitus may occur when basement membrane dysfunction or damage causes ionic disequilibrium and neuroepithelial damage. Of note, all of the patients in this study exhibit stage 4 Meniere's disease, exhibiting profound deafness and intractable recurrent vertigo spells.In conclusion, the altered expression of AQP4 and AQP6 in the supporting cells of endorgans acquired from patients with intractable Meniere's disease may play a role in the formation of endolymphatic hydrops and may be directly associated with neuroepithelial dysfunction.
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